Issue Date | Title | Involved Person(s) |
2017 | Emodin : a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents | Abu Eid, Sameer; Adams, Michael; Scherer, Thomas; Torres-Gómez, Héctor Manuel; Hackl, Martina Theresa; Kaplanian, Mairam; Riedl, Rainer; Luger, Anton; Fürnsinn, Clemens |
2017 | Pseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerase | Chellat, Mathieu F.; Riedl, Rainer |
Sep-2016 | Emodin, a compound with acclaimed antidiabetic potential, deteriorates glucose tolerance in obese mice | Abu Eid, S.; Adams, M.; Scherer, T.; Torres-Gómez, H.; Hackl, M.T.; Riedl, R.; Luger, A.; Fürnsinn, C. |
24-Oct-2015 | Emodin, eine mutmaßlich anti-diabetisch wirksame Verbindung, beeinträchtigt die Glukosetoleranz adipöser Mäuse | Abu Eud, Sameer; Adams, Michael; Scherer, Thomas; Torres-Gomez, Hector; Riedl, Rainer; Luger, Anton; Fürnsinn, Clemens |
25-Feb-2015 | Cover Picture: Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural‐product‐derived fragments (ChemMedChem 3/2015) | Lanz, Jan; Riedl, Rainer |
2014 | Fighting the resistance | Riedl, Rainer |
2014 | Nicht nur Metalloproteasen im Visier | Riedl, Rainer |
25-Sep-2013 | Tackling antibiotic resistance | Riedl, Rainer |
Jan-2013 | Organic chemistry : the heart and soul of drug discovery | Riedl, Rainer |
2013 | Bridging the disciplines : cancer diagnostics & treatment | Riedl, Rainer |